Prilosec Mixed Verdict Would Complicate Generic Marketing Exclusivity

Schwarz Pharma is exploring a scenario where it would win a favorable decision in the Prilosec patent case, while generic omeprazole marketing exclusivity holder Andrx loses on non-infringement